Discussion on machine learning technology to predict tacrolimus blood concentration in patients with nephrotic syndrome and membranous nephropathy in real-world settings

BACKGROUND: Given its narrow treatment window, high toxicity, adverse effects, and individual differences in its use, we collected and sorted data on tacrolimus use by real patients with kidney diseases. We then used machine learning technology to predict tacrolimus blood concentration in order to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Weijia, Sui, Lin, Xin, Haili, Liu, Minchao, Shi, Huayu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764593/
https://www.ncbi.nlm.nih.gov/pubmed/36539772
http://dx.doi.org/10.1186/s12911-022-02089-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764593/
https://www.ncbi.nlm.nih.gov/pubmed/36539772
http://dx.doi.org/10.1186/s12911-022-02089-w

Ejemplares similares